Loading…
NewGenIvf Group Limited is projected to decline to $0.5871 by 2027, a -10% move from its current price of $0.653. NIVF is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.6155 | $0.6524 | $0.6915 | -0.10% |
| Aug 6 | $0.6002 | $0.6517 | $0.7077 | -0.19% |
| Aug 7 | $0.5886 | $0.6511 | $0.7202 | -0.29% |
| Aug 8 | $0.5789 | $0.6505 | $0.7308 | -0.39% |
| Aug 9 | $0.5705 | $0.6498 | $0.7402 | -0.49% |
| Aug 10 | $0.5629 | $0.6492 | $0.7487 | -0.58% |
| Aug 11 | $0.556 | $0.6486 | $0.7566 | -0.68% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.556 | $0.6486 | $0.7566 | -0.68% |
| Week 2 | $0.518 | $0.6442 | $0.801 | -1.35% |
| Week 3 | $0.4899 | $0.6398 | $0.8355 | -2.03% |
| Week 4 | $0.4669 | $0.6354 | $0.8648 | -2.69% |
| Week 5 | $0.4472 | $0.6311 | $0.8907 | -3.35% |
| Week 6 | $0.4298 | $0.6268 | $0.9142 | -4.01% |
| Week 7 | $0.4141 | $0.6226 | $0.9359 | -4.66% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NewGenIvf Group Limited is an investment holding company that provides an assisted reproductive service to help couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company was founded in 2010 and is based in Bangkok, Thailand.
Its services span a wide range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. Clinics deliver these services across the regions described above.
NewGenIvf Group Limited (NIVF) is currently trading with a price of $0.8539 and a market capitalization of $2.92M, ranking 5393 by market cap.
For 2026, the forecast shows a narrow movement around the current level: min $0.8539, avg $0.8539, max $0.9297, ROI 0, sentiment NEUTRAL.
Looking further out, the forecast highlights a bullish turn in 2040 (avg $1.28, max $2.82, ROI 50.4, sentiment BULLISH) and in 2050 (avg $1.62, max $3.73, ROI 89.9, sentiment BULLISH).
The technical profile shows SMA50 at $1.83 and SMA200 at $36.41, RSI14 at 20, and a 30-day trading range of $0.5689–$1.28, with near-term support at $0.854 and resistance at $2.40.
A major floor 29.4% below — a decisive break under it would weaken the trend.
Support has flipped 24.0% overhead — reclaiming it would be bullish.
The nearest ceiling, 248.2% above — a clean break opens room to run.
A major ceiling 281.3% above — clearing it would confirm fresh momentum.
Key NIVF support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NIVF market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.8988 | Sell | $0.9063 | Sell |
| MA 10 | $1.07 | Sell | $1.01 | Sell |
| MA 20 | $1.22 | Sell | $1.05 | Sell |
| MA 50 | $0.912 | Sell | $1.22 | Sell |
| MA 100 | $1.36 | Sell | $10.15 | Sell |
| MA 200 | $11.14 | Sell | $217.45 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.06 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -158.58 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -40.88 | Sell |
| Bollinger %B (20,2) | 0.00 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 1.02 | Buy |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 8.47 | Buy |
| Momentum (10) | -0.51 | Sell |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 0.76 | Sell |
| ADX (14) | 22.41 | Sell |
| ATR (14) | 0.07 | Info |
The near-term technical picture is NEUTRAL, with RSI14 at 20 indicating weak momentum.
The 30-day range spans from $0.5689 to $1.28, placing current activity near the lower end of recent prices.
Key levels include support at $0.854 and resistance at $2.40, while the short-term momentum is influenced by the gap between the price and the SMA200 ($36.41) and the closer SMA50 ($1.83).
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.653 | $0.653 | $0.7123 | 0% | Neutral | |
| $0.4278 | $0.5871 | $0.8706 | -10% | Neutral | |
| $0.3574 | $0.5216 | $0.8255 | -20% | Bearish | |
| $0.2783 | $0.4281 | $0.7116 | -34% | Bearish | |
| $0.2961 | $0.4776 | $0.827 | -27% | Bearish | |
| $0.3558 | $0.5999 | $1.08 | -8% | Neutral | |
| $0.4172 | $0.7338 | $1.36 | +12% | Neutral | |
| $0.3893 | $0.7131 | $1.36 | +9% | Neutral | |
| $0.3256 | $0.6205 | $1.21 | -5% | Neutral | |
| $0.3104 | $0.6148 | $1.23 | -6% | Neutral | |
| $0.4474 | $0.9942 | $2.18 | +52% | Bullish | |
| $0.5541 | $1.23 | $2.83 | +89% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.653 | $0.653 | $0.7599 | +0.00% |
| September 2026 | $0.4835 | $0.5877 | $0.7453 | -10.00% |
| October 2026 | $0.4848 | $0.5975 | $0.7732 | +1.67% |
| November 2026 | $0.4626 | $0.5767 | $0.7584 | -3.48% |
| December 2026 | $0.4238 | $0.5339 | $0.7123 | -7.43% |
Click any year to see its month-by-month NIVF forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NIVF price prediction for 2026 points to an average of $0.653 (low $0.653, high $0.7123) — a potential gain of 0% on today's $0.653. Price action looks broadly range-bound.
In 2027, NIVF is projected to trade between $0.4278 and $0.8706, averaging $0.5871 — a potential decline of -10% from today's $0.653. That is -10% versus the projected 2026 average. A consolidation phase looks the most probable path here.
NewGenIvf Group Limited's 2028 outlook centres on $0.5216, within a $0.3574 to $0.8255 range. That is -11% versus the projected 2027 average. That marks a -20% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2029, NIVF could reach as high as $0.7116, with a base case around $0.4281 and support toward $0.2783 — roughly -34% from $0.653. Expect choppier, lower action through this leg of the cycle.
Expect NIVF to range from $0.2961 to $0.827 through 2030. The $0.4776 average target implies a -27% move from current prices. That is up +12% on the projected 2029 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The NIVF price prediction for 2031 points to an average of $0.5999 (low $0.3558, high $1.08) — a potential decline of -8% on today's $0.653. A consolidation phase looks the most probable path here.
In 2032, NIVF is projected to trade between $0.4172 and $1.36, averaging $0.7338 — a potential gain of +12% from today's $0.653. That is up +22% on the projected 2031 average. Price action looks broadly range-bound.
NewGenIvf Group Limited's 2033 outlook centres on $0.7131, within a $0.3893 to $1.36 range. That is -3% versus the projected 2032 average. That marks a +9% change versus current levels. A consolidation phase looks the most probable path here.
By 2034, NIVF could reach as high as $1.21, with a base case around $0.6205 and support toward $0.3256 — roughly -5% from $0.653. Price action looks broadly range-bound.
Expect NIVF to range from $0.3104 to $1.23 through 2035. The $0.6148 average target implies a -6% move from current prices. That is -1% versus the projected 2034 average. A consolidation phase looks the most probable path here.
The NIVF price prediction for 2040 points to an average of $0.9942 (low $0.4474, high $2.18) — a potential gain of +52% on today's $0.653. Momentum favours further upside here.
In 2050, NIVF is projected to trade between $0.5541 and $2.83, averaging $1.23 — a potential gain of +89% from today's $0.653. That is up +24% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NIVF today (≈ 1,531.393568 NIVF) could be worth
$1,885.71
+$885.71 (+89%) by 2050 · US Dollar
Based on the average projected NIVF price of $1.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NIVFwould be worth at today's price.
$1,000 invested in NIVF on Jul 31, 2025 (≈ 7.662835 NIVF) would be worth
$5
-$995 (-99.5%) today · 0.01× · US Dollar
Based on a NIVF entry price of $130.5 vs. today's $0.653.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.1 | $593.64 | -40.6% |
| 1 month ago | $0.551 | $1,185.12 | +18.5% |
| 3 months ago | $1.71 | $381.87 | -61.8% |
| 6 months ago | $5.2 | $125.58 | -87.4% |
| 1 year ago | $130.5 | $5 | -99.5% |
| All time (4.4y) ago | $29,490 | $0.02 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NIVF forecast.
$1.30 is within our bullish range by 2032, but above the base case.
Implied market cap at $1.30: $4.45M
The multi-year forecast shows a mixed path through 2026–2035, with 2026 presenting a neutral stance (min $0.8539, avg $0.8539, max $0.9297; ROI 0; sentiment NEUTRAL).
From 2027 to 2035, the path is largely bearish or neutral: 2027 avg $0.7772, ROI -9; 2028 avg $0.6773, ROI -20.7; 2029 avg $0.5536, ROI -35.2; 2030 avg $0.6371, ROI -25.4; 2031 avg $0.7852, ROI -8.1; 2032 avg $0.956, ROI 12; 2033 avg $0.9404, ROI 10.1; 2034 avg $0.803, ROI -6; 2035 avg $0.8054, ROI -5.7.
A shift occurs in 2040, with avg $1.28, max $2.82 and ROI 50.4, followed by a further bullish tilt in 2050 with avg $1.62, max $3.73 and ROI 89.9.
These figures reflect estimates across a range of outcomes and are not guarantees; they illustrate potential trajectories with notable upside in the later years amid earlier periods of weakness.
Tap a question to reveal the answer.
The 2030 forecast shows min $0.3948, avg $0.6371, max $1.10 with ROI -25.4% and sentiment BEARISH. These are estimates and not guarantees.
Forecasts show a mixed path: 2026 avg $0.8539 with ROI 0 and sentiment NEUTRAL, transitioning to bullish by 2040 (ROI 50.4) and 2050 (ROI 89.9). These figures are estimates, not guarantees.
The 2040 max is $2.82 and the 2050 max is $3.73, so surpassing $2.40 is possible in later years, while earlier years show lower ceilings (e.g., 2030 max $1.10). These are forward-looking estimates, not guarantees.
Current price is $0.8539 and market capitalization is $2.92M. These figures reflect the latest data provided.
For 2032, min $0.5433, avg $0.956, max $1.77 with ROI 12 and sentiment NEUTRAL. These are estimates, not guarantees.
NewGenIvf Group Limited Community Discussion
0Share your NewGenIvf Group Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.